StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
381
This month
2
This year
24
Publishing Date
2024 - 02 - 14
4
2023 - 12 - 01
4
2023 - 10 - 25
3
2023 - 05 - 18
2
2023 - 05 - 15
2
2023 - 04 - 28
3
2023 - 04 - 25
4
2023 - 03 - 30
2
2023 - 03 - 23
2
2023 - 03 - 16
2
2023 - 03 - 14
2
2023 - 03 - 08
3
2023 - 02 - 06
2
2022 - 12 - 22
2
2022 - 12 - 06
2
2022 - 11 - 30
3
2022 - 11 - 02
2
2022 - 10 - 26
3
2022 - 10 - 17
2
2022 - 09 - 28
2
2022 - 09 - 27
2
2022 - 09 - 19
3
2022 - 09 - 16
2
2022 - 08 - 03
2
2022 - 07 - 26
2
2022 - 07 - 15
4
2022 - 07 - 08
3
2022 - 06 - 03
3
2022 - 05 - 09
2
2022 - 05 - 02
2
2022 - 04 - 27
2
2022 - 03 - 16
3
2022 - 03 - 14
3
2022 - 03 - 07
3
2022 - 03 - 05
2
2022 - 03 - 04
4
2022 - 01 - 27
2
2021 - 12 - 17
2
2021 - 12 - 16
2
2021 - 11 - 16
2
2021 - 11 - 11
2
2021 - 10 - 13
2
2021 - 09 - 21
2
2021 - 09 - 20
2
2021 - 09 - 09
3
2021 - 07 - 29
3
2021 - 07 - 08
3
2021 - 06 - 29
2
2021 - 06 - 17
3
2021 - 06 - 10
2
2021 - 06 - 07
2
2021 - 05 - 12
2
2021 - 04 - 28
3
2021 - 04 - 20
2
2021 - 04 - 19
2
2021 - 04 - 09
4
2021 - 02 - 11
3
2021 - 02 - 10
2
2021 - 02 - 04
2
2021 - 01 - 08
2
Sector
Commercial services
2
Communications
2
Consumer non-durables
3
Consumer services
1
Distribution services
1
Electronic technology
8
Energy minerals
1
Finance
4
Health services
4
Health technology
381
Information
4
Manufacturing
23
N/a
8
Process industries
1
Producer manufacturing
7
Professional, scientific, and technical services
4
Retail trade
8
Technology services
12
Utilities
2
Tags
Aduhelm
6
Alliances
12
Alzheimer
24
Alzheimer's
45
Alzheimer's disease
20
Alzheimer’s
37
America
10
Antibody
9
Application
23
Approval
20
Biomarkers
7
Biosimilar
12
Biotech
6
Cancer
6
Collaboration
12
Conference
12
Depression
7
Disease
74
Drug
28
Europe
11
Events
7
Fda
32
Financial
6
Genetic
6
Genetown
24
Global
24
Grants
8
Growing
9
Growth
36
Health
6
International
6
Lecanemab
35
Leqembi
6
License
16
Market
73
Meeting
6
Multiple sclerosis
10
N/a
264
Neurological
6
People
20
Phase 2
13
Phase 2b
6
Phase 3
12
Pipeline
7
Positive
13
Potential
15
Rare
7
Report
18
Research
34
Results
24
Review
9
Sclerosis
16
Study
14
Submission
12
Technology
7
Therapeutics
52
Therapy
30
Topline
6
Treatment
41
Trial
13
Entities
Abbott laboratories
8
Abbvie inc.
37
Abeona therapeutics inc.
7
Absci corp
4
Adaptimmune therapeutics plc
7
Alibaba group holding limited
6
Alkermes plc
5
Alnylam pharmaceuticals, inc.
5
Amarin corporation plc
3
Amgen inc.
49
Apple inc.
4
Aravive, inc.
3
Astellas pharma inc
11
Astrazeneca plc
22
Bausch health companies inc.
7
Baxter international inc.
11
Biogen inc.
381
Bluebird bio, inc.
3
Brainstorm cell therapeutics inc.
5
Bristol-myers squibb company
11
Ciena corporation
3
Cytodyn inc.
4
Denali therapeutics inc.
14
Durect corporation
3
Editas medicine, inc.
3
Eli lilly and company
20
Emcore corporation
3
Galapagos nv
4
Generation bio co.
7
Gilead sciences, inc.
6
Glaxosmithkline plc
24
Grifols sa
4
Honeywell international inc.
3
Incyte corporation
4
Intel corporation
6
Invivo therapeutics holdings corp.
4
Ionis pharmaceuticals, inc.
23
Iovance biotherapeutics, inc.
4
Jazz pharmaceuticals plc
4
Johnson & johnson
29
Kamada ltd.
4
Lockheed martin corporation
6
Medtronic plc
3
Microsoft corporation
6
Nec corp
3
Nokia corp
3
Nokia corporation
6
Novartis ag
54
Novo nordisk a/s
7
Orchard therapeutics plc
8
Polypid ltd.
3
Quantum computing inc
3
Reata pharmaceuticals, inc.
3
Regeneron pharmaceuticals, inc.
4
Sage therapeutics, inc.
20
Sanofi
53
Takeda pharmaceutical company limited
6
Teva pharmaceutical industries ltd
28
Thermo fisher scientific inc
7
Viatris inc.
15
Symbols
A
429
ABBV
1029
ABT
1796
ALPMF
333
ALPMY
333
AMGN
744
AZN
667
AZNCF
450
BAX
484
BDX
796
BGNE
324
BHC
389
BIIB
381
BIO
449
BMY
662
BNTX
367
BSX
576
BWAY
330
DHR
786
FNCTF
490
GILD
500
GLAXF
661
GMAB
298
GOOG
306
GOOGL
307
GSK
887
HEPA
404
HOLX
328
ILMN
451
INCY
445
JNJ
4595
LLY
1710
MDT
1286
MOR
318
MPSYF
274
MRK
337
MRNA
350
MS
621
NKTR
369
NVO
634
NVS
1244
NVSEF
1034
OCX
485
PFE
693
PHG
963
PKI
274
PRVB
348
QGEN
369
REGN
421
RYLPF
440
SNY
4550
SNYNF
3608
STRO
270
SYK
536
TAK
423
TEVJF
632
TMO
1627
TXMD
281
VTRS
365
VXRT
317
Exchanges
Amex
3
Nasdaq
381
Nyse
126
Crawled Date
2024 - 02 - 14
4
2023 - 12 - 01
4
2023 - 10 - 25
3
2023 - 05 - 15
2
2023 - 04 - 28
3
2023 - 04 - 25
4
2023 - 03 - 31
2
2023 - 03 - 23
2
2023 - 03 - 16
2
2023 - 03 - 14
2
2023 - 03 - 08
3
2023 - 03 - 06
2
2023 - 02 - 06
2
2022 - 12 - 09
2
2022 - 12 - 06
2
2022 - 11 - 30
3
2022 - 11 - 02
2
2022 - 10 - 26
3
2022 - 10 - 17
2
2022 - 09 - 28
3
2022 - 09 - 19
3
2022 - 09 - 16
2
2022 - 08 - 04
2
2022 - 07 - 26
2
2022 - 07 - 15
4
2022 - 07 - 08
3
2022 - 07 - 06
2
2022 - 06 - 03
3
2022 - 05 - 02
2
2022 - 04 - 27
2
2022 - 03 - 16
3
2022 - 03 - 14
2
2022 - 03 - 07
3
2022 - 03 - 05
3
2022 - 03 - 04
4
2021 - 12 - 17
2
2021 - 12 - 16
2
2021 - 11 - 16
2
2021 - 11 - 11
2
2021 - 10 - 18
2
2021 - 10 - 13
2
2021 - 09 - 28
2
2021 - 09 - 23
2
2021 - 09 - 21
2
2021 - 09 - 20
2
2021 - 09 - 09
3
2021 - 07 - 29
3
2021 - 07 - 08
3
2021 - 06 - 29
2
2021 - 06 - 17
3
2021 - 06 - 10
2
2021 - 06 - 07
2
2021 - 05 - 12
2
2021 - 04 - 28
3
2021 - 04 - 20
3
2021 - 04 - 09
4
2021 - 02 - 11
3
2021 - 02 - 10
2
2021 - 02 - 04
2
2021 - 01 - 08
2
Crawled Time
00:00
30
00:01
1
00:20
1
01:00
15
02:00
4
03:00
8
04:00
5
04:20
4
05:00
2
06:00
3
07:00
3
08:00
6
08:20
1
09:00
6
10:00
4
11:00
23
11:33
1
12:00
47
12:15
5
12:20
8
12:30
6
13:00
31
13:01
1
13:03
1
13:04
1
13:15
1
13:20
2
13:30
9
14:00
16
14:03
2
14:15
2
14:20
2
14:30
3
15:00
19
15:15
1
15:20
3
15:30
3
16:00
11
16:07
2
16:20
2
17:00
11
17:07
1
18:00
10
18:03
1
18:04
1
19:00
13
20:00
10
20:20
1
21:00
20
22:00
6
23:00
12
Source
investor.alkermes.com
2
ir.voyagertherapeutics.com
1
www.biospace.com
117
www.fda.gov
1
www.globenewswire.com
103
www.prnewswire.com
157
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
symbols :
Biib
save search
EISAI TO PRESENT DATA ON ROBUST NEUROLOGY PORTFOLIO AT THE 76th AMERICAN ACADEMY OF NEUROLOGY® (AAN) ANNUAL MEETING
Published:
2024-04-12
(Crawled : 12:00)
- prnewswire.com
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-3.98%
|
O:
1.03%
H:
0.49%
C:
-2.96%
neurology
meeting
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Published:
2024-04-02
(Crawled : 12:00)
- globenewswire.com
AVTX
|
$12.82
5.0%
4.76%
73K
|
Manufacturing
|
-37.16%
|
O:
-22.8%
H:
15.52%
C:
1.07%
ICLR
|
News
|
$306.16
2.76%
2.68%
860K
|
Health Technology
|
-11.67%
|
O:
-2.95%
H:
0.0%
C:
-1.43%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-9.92%
|
O:
-1.11%
H:
0.16%
C:
-2.56%
biotech
leaders
therapeutics
Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
Published:
2024-03-31
(Crawled : 00:00)
- prnewswire.com
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-10.71%
|
O:
-0.88%
H:
0.0%
C:
0.0%
leqembi
fda
disease
license
treatment
alzheimer's
application
submission
Dyne Therapeutics Announces CEO Transition
Published:
2024-03-25
(Crawled : 12:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.09%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.73%
|
O:
0.42%
H:
0.0%
C:
0.0%
DYN
|
$25.44
2.29%
2.24%
810K
|
Health Technology
|
-11.93%
|
O:
-13.24%
H:
11.02%
C:
6.37%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-11.0%
|
O:
-0.15%
H:
0.23%
C:
-0.5%
ceo
therapeutics
Pilates Equipment Market size to grow by USD 101.05 million from 2022 to 2027, North America to account for 37% of the growth, Technavio
Published:
2024-03-19
(Crawled : 21:00)
- prnewswire.com
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-11.22%
|
O:
-0.66%
H:
1.0%
C:
0.45%
america
million
market
Global Neutropenia Market Poised to Reach USD 5.86 Billion by 2028, Amid Rising Cancer Incidence and Advancements in Treatment Options
Published:
2024-03-18
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.31%
|
O:
-0.02%
H:
0.0%
C:
0.0%
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
-2.74%
|
O:
0.02%
H:
1.03%
C:
0.96%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.65%
|
O:
-1.51%
H:
0.0%
C:
0.0%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-8.61%
|
O:
0.11%
H:
0.59%
C:
0.1%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-11.53%
|
O:
-0.48%
H:
0.31%
C:
0.13%
reach
cancer
treatment
global
market
World Cancer Immunotherapy Market Research 2023-2027: Curing Cancer is Generating Enormous New Opportunities - Outcome Potential, Technology Environment, Target Solutions
Published:
2024-03-16
(Crawled : 04:20)
- prnewswire.com
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
world
cancer
research
solutions
immunotherapy
technology
market
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million, 42% of market growth is expected in North America, Technavio
Published:
2024-03-12
(Crawled : 04:00)
- prnewswire.com
ELDN
|
$2.15
6.44%
6.05%
190K
|
Manufacturing
|
16.76%
|
O:
1.73%
H:
1.7%
C:
-7.39%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.26%
|
O:
0.01%
H:
0.0%
C:
0.0%
DNLI
|
$16.11
0.75%
0.74%
1.1M
|
Health Technology
|
-26.28%
|
O:
-0.6%
H:
0.74%
C:
-3.66%
BCLI
A
|
$0.531
-1.69%
-1.71%
170K
|
Health Technology
|
64.13%
|
O:
-2.43%
H:
2.8%
C:
-4.02%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-15.63%
|
O:
-0.32%
H:
0.18%
C:
-0.86%
expected
sclerosis
treatment
growth
market
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
ABCL
|
$3.985
-0.62%
-0.63%
1.6M
|
|
-15.93%
|
O:
5.03%
H:
0.0%
C:
0.0%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-13.05%
|
O:
0.03%
H:
3.1%
C:
3.03%
neurological
New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy
Published:
2024-03-06
(Crawled : 12:30)
- globenewswire.com
IONS
|
$41.85
1.9%
1.86%
630K
|
Health Technology
|
-7.06%
|
O:
0.05%
H:
1.32%
C:
0.18%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-10.64%
|
O:
0.11%
H:
1.16%
C:
0.04%
spinraza
biomarker
potential
therapy
Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual Meeting
Published:
2024-03-04
(Crawled : 21:00)
- globenewswire.com
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-12.18%
|
O:
-0.62%
H:
0.84%
C:
-1.1%
conference
alzheimer’s
international
meeting
parkinson’s
Amprion's αSyn Seed Amplification Assay (αS-SAA) Highlighted in 10 Presentations at AD/PD™ 2024 International Conference
Published:
2024-03-04
(Crawled : 19:00)
- prnewswire.com
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-12.18%
|
O:
-0.62%
H:
0.84%
C:
-1.1%
conference
international
Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
Published:
2024-02-23
(Crawled : 12:00)
- globenewswire.com
IONS
|
$41.85
1.9%
1.86%
630K
|
Health Technology
|
-6.62%
|
O:
0.25%
H:
2.95%
C:
2.88%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-12.75%
|
O:
0.43%
H:
1.06%
C:
-0.05%
qalsody
first
chmp
genetic
positive
treat
therapy
Biosimilar Lymphocyte Modulator Global Market Report 2024 - Robust 10.6% CAGR Forecast, Amid Rising Autoimmune Disease Prevalence
Published:
2024-02-20
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-4.99%
|
O:
2.81%
H:
0.0%
C:
-0.95%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.41%
|
O:
2.91%
H:
0.35%
C:
-0.38%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-11.4%
|
O:
-0.69%
H:
1.24%
C:
0.76%
disease
biosimilar
report
global
market
9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published:
2024-02-19
(Crawled : 16:00)
- prnewswire.com
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
Email alert
Add to watchlist
JAZZ
|
$109.685
0.79%
0.78%
380K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
cancer
cell
global
growth
market
Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
Published:
2024-02-14
(Crawled : 15:00)
- biospace.com/
SAGE
|
$12.94
0.39%
0.39%
810K
|
Health Technology
|
-44.01%
|
O:
9.69%
H:
8.48%
C:
1.98%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-14.36%
|
O:
0.16%
H:
0.43%
C:
-2.76%
business
year
pipeline
therapeutics
financial
results
Biosimilar Hormones Global Market Report 2024 - Niche Sectors Record Notable Market Contributions
Published:
2024-02-14
(Crawled : 03:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-14.36%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.39%
|
O:
-0.21%
H:
0.34%
C:
0.07%
biosimilar
report
global
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$541.144
-19.1%
24
|
Health Technology
|
8.23%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-3.33%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
12.33%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$55.69
0.02%
29K
|
Professional, Scientific, and T...
|
12.17%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
News
|
$574.59
4.78%
-1.12%
2.5M
|
Health Technology
|
1.82%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-6.83%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-5.44%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-1.93%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
1.97%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-3.77%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-4.89%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
News
|
$29.47
1.38%
1.36%
120K
|
Health Technology
|
-25.58%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-14.36%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
14.91%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.39%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published:
2024-02-14
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-3.33%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
12.33%
|
O:
0.87%
H:
0.21%
C:
-2.23%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-1.93%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
VRTX
|
$404.93
1.25%
1.43%
1.1M
|
Health Technology
|
-4.44%
|
O:
0.56%
H:
0.49%
C:
-0.12%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-14.36%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
14.91%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.39%
|
O:
-0.21%
H:
0.34%
C:
0.07%
disease
report
treatment
expansion
global
infections
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-1.11%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
14.97%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-11.92%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-6.64%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.73%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.78%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-1.17%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-0.8%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-1.23%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-2.99%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$15.13
0.93%
0.93%
470K
|
Health Technology
|
-17.68%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$404.93
1.25%
1.43%
1.1M
|
Health Technology
|
-5.01%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.16%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-6.2%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$51.62
-0.58%
-0.58%
2.5M
|
Health Technology
|
-10.24%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-20.69%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
14.2%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$375.13
1.73%
1.7%
340K
|
Health Technology
|
-6.1%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-7.65%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
← Previous
1
2
3
4
5
6
7
8
9
…
19
20
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
M
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.